EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Intravenous Tranexamic Acid Reduces Perioperative Blood Loss in Reduction Mammoplasty With Immediate Implant-Based Reconstruction: A Randomized, Triple-Blinded, Placebo-Controlled Trial

Jerzy Kolasiński, Tomasz Reysner, Małgorzata Kolenda, Szymon Kołacz, Małgorzata Reysner iD

Aesthetic Surgery Journal · 2026

DOI: 10.1093/asj/sjaf258 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, 2026. Verfasst von Jerzy Kolasiński und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tranexamic Acid, Antifibrinolytic Agents, Blood Loss, Surgical, Mammaplasty. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative hematoma and oozing can compromise outcomes after reduction mammoplasty with immediate reconstruction. Intravenous (IV) tranexamic acid (TXA) is antifibrinolytic, but prospective evidence in this setting is limited.

Objectives

The aim of this study was to determine whether a single pre-incision dose of IV TXA reduces perioperative blood loss and fibrinolytic activation vs placebo.

Methods

In this randomized, triple-blinded, placebo-controlled trial, 60 women (American Society of Anesthesiologists I/II, 18-75 years) undergoing bilateral reduction mammoplasty with immediate implant-based reconstruction received TXA 10 mg/kg in 100 mL saline or placebo 10 min before incision. The primary outcome was total blood loss within 24 h (intraoperative suction + swab plus drain output). Secondary outcomes were perioperative changes in hemoglobin, D-dimer and fibrinogen, and complications within 30 days. Intention-to-treat analyses were performed.

Results

All patients completed follow-up. Total blood loss was lower with TXA than with placebo (mean ± standard deviation: 221.1 ± 72.4 vs 298.1 ± 90.6 mL; mean difference −77.0 mL; 95% CI, −122.4 to −31.6; P = .001). Intraoperative loss and 24 h drain output were also reduced. Postoperative D-dimer rise was attenuated with TXA (0.31 ± 0.15 vs 0.49 ± 0.22 µg/mL; P = .002); hemoglobin decline was smaller. No thromboembolic, neurologic, or allergic events occurred; no skin-flap necrosis was observed.

Conclusions

Pre-incisional IV TXA safely reduces perioperative bleeding and fibrinolytic activity after reduction mammoplasty. These findings support incorporation of IV TXA into perioperative protocols. Level of Evidence: 2 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidAntifibrinolytic AgentsBlood Loss, SurgicalMammaplastyBreast ImplantationPostoperative HemorrhageHumansFemaleAdultMiddle AgedYoung AdultTreatment OutcomeAdolescentAgedAdministration, IntravenousProspective StudiesFibrin Fibrinogen Degradation ProductsTime FactorsDouble-Blind Method

Substanzen

Tranexamic AcidAntifibrinolytic AgentsFibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

ORCID-Profile: Małgorzata Reysner

Zitieren

APA

Kolasiński, J., Reysner, T., Kolenda, M., Kołacz, S., & Reysner, M. (2026). Intravenous Tranexamic Acid Reduces Perioperative Blood Loss in Reduction Mammoplasty With Immediate Implant-Based Reconstruction: A Randomized, Triple-Blinded, Placebo-Controlled Trial. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjaf258

Vancouver

Kolasiński J, Reysner T, Kolenda M, Kołacz S, Reysner M. Intravenous Tranexamic Acid Reduces Perioperative Blood Loss in Reduction Mammoplasty With Immediate Implant-Based Reconstruction: A Randomized, Triple-Blinded, Placebo-Controlled Trial. Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjaf258

BibTeX
@article{Kolasiski2026,
  author = {Kolasiński, Jerzy and Reysner, Tomasz and Kolenda, Małgorzata and Kołacz, Szymon and Reysner, Małgorzata},
  title = {Intravenous Tranexamic Acid Reduces Perioperative Blood Loss in Reduction Mammoplasty With Immediate Implant-Based Reconstruction: A Randomized, Triple-Blinded, Placebo-Controlled Trial},
  journal = {Aesthetic Surgery Journal},
  year = {2026},
  doi = {10.1093/asj/sjaf258}
}
Kostenlos starten →